News

City of San Antonio enacting plan to better leverage military medical assets

  The San Antonio Military Life Science Commercialization Action Plan seeks to better leverage ...

Rapamycin Holdings Treats First Humans in eRapa Clinical Trial

Featured image is of SwRI staff working in their cGMP clean room where clinical supplies of their ...

Events

Learn to Prepare IND for Small Molecule Drugs

How does a drug development program evolve from a brilliant research idea? Join Southwest Research Institute ...
News
San Antonio’s Mission Pharmacal rolls out two new products
November 19, 2015

By Peggy O'Hare on November 19, 2015 at 3:27 PM

San Antonio pharmaceutical company Mission Pharmacal has introduced two new medications for adults suffering from coughs and colds.

The company has nationally launched HycofenixT Oral Solution, a prescription medication that relieves three cough and cold symptoms. The product features the first and only combination of hydrocodone, pseudoephedrine and guaifenesin approved by the U.S. Food and Drug Administration.

Hycofenix relieves coughing, loosens respiratory secretions for a more productive cough and clears nasal congestion.

Mission Pharmacal also launched another new product, FlowtussT Oral Solution, a prescription that relieves coughing and loosens respiratory secretions. The medication is an option for patients who are coughing, but do not need a nasal decongestant. It contains hydrocodone bitartrate and guaifenesin.

Both medications come in a black raspberry flavor and have been approved by the FDA for patients 18 years old and older.

To support customer needs related to Hycofenix and Flowtuss, we have nearly doubled the size of our sales team, said John McLaughlin, sales director of Mission Pharmacal’s primary care division. We are excited that the addition of these products in a new therapeutic class enables us to grow and better serve primary care providers and their patients.

Stay informed. Subscribe to BioMed SA news alerts.